KKR veteran launches healthcare private equity firm

Jim Momtazee, a 21-year veteran of KKR, has launched his own investment firm, Patient Square Capital, with an aim of managing large pools of capital with the expertise to meet the ‘considerable and critical’ needs of the healthcare world. Formerly at KKR, Momtazee helped form the healthcare industry group and subsequently served as head of the Americas Health Care Team for more than a decade. During Momtazee's tenure high-profile investments included Jazz Pharmaceuticals (2004); HCA (2006), a $33 billion transaction which at the time was the largest cash buyout in history; PRA Health Sciences (2013); and BridgeBio Pharma (2016). In forming the new Menlo, California-based Patient Square, he is joined by Maria Walker, who is partner and CFO of the new firm and was most recently founder and CEO of Recuerdo Therapeutics and previously a global lead in the private equity practice at KPMG. "In an industry as critical, complex, and capital intensive as healthcare, there exists a need for a specialized investment firm with substantial scale that is built for and focused every day on health," said Momtazee, managing partner of Patient Square. "Successful healthcare organizations relentlessly focus on the patient. A successful and enduring healthcare investment firm must do the same. Patient Square is the combination of a patient approach to investing and a patient-centered orientation." Patient Square will seek opportunities to invest broadly across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health. "Focus and experience will drive excellence in everything we do," added Walker. "Patient Square Capital, as a dedicated healthcare firm, will make outstanding investments through its depth of relationships, insight, and resources, while maintaining the highest standards of communication and transparency to investors."

Continue Reading With a Free Trial

Be an Alts Watcher

Subscribe to our mailing list and know first!

Blackstone Life Sciences funds R&D for Alnylam

FTV invests in enterprise workflow specialist Agiloft

Related Articles

MassPRIM plots $18bn diverse asset manager program

Yale’s Swensen remembered as an alternative investing pioneer

Preparing your hedge fund for the modern cybercriminal

Barometer Capital launches Canadian music rights fund

Get our daily news digest in your inbox

Get our daily news digest
in your inbox